Dural Graft Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Dural Graft market is poised for remarkable growth, with a projected valuation of approximately US$ 1300 Million by the end of 2031, up from US$ 799 Million in 2024. This impressive surge can be attributed to a combination of factors, including the rising incidence of neurological disorders, heightened awareness surrounding neurological conditions, and the preference for advanced graft materials.

Rising Incidence of Neurological Disorders and Increasing Awareness about Neurological Conditions

Neurological disorders have become a significant global health concern, contributing substantially to the global disease burden. According to a study published in Frontiers in 2022, neurological disorders resulted in 349 million Disability-Adjusted Life Years (DALYs) and over 10 million fatalities worldwide in 2019. Stroke emerged as the leading cause of DALYs among the 18 neurological illnesses studied.

In recognition of the gravity of this issue, the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031 was adopted by the 75th World Health Assembly in May 2022. This initiative prioritizes brain health for the next decade, acknowledging that neurological illnesses are the primary cause of disability and the second greatest cause of death globally.

This concerted effort to address neurological disorders, coupled with increased awareness, is driving the growth of the dural graft market.

Increased Preference for Xerographic Dural Grafts and Advanced Dural Graft Material

Many neurosurgeons favor natural and biological source dural grafts, such as xerographic dural grafts, due to their superior patient compatibility and fewer postoperative complications. Next-generation synthetic dural grafts are also expected to gain traction thanks to advancements in material nanotechnology and scientific principles. These bio-absorbable, nanostructured synthetic grafts offer affordability and improved patient comfort, making them a preferred choice among neurosurgeons.

Market Growth Challenges

Despite the promising prospects, the dural graft market faces challenges that could potentially impede its growth. One notable obstacle is the shortage of skilled neurosurgeon workers. The demand for neurosurgeons specializing in dural graft surgeries is high, yet the insufficient availability of qualified personnel results in more than 5 million neurosurgical cases going untreated each year. Furthermore, the overall high cost associated with neurosurgeries, from hospitalization to post-operative care, is expected to slow down market expansion.

Country-wise Insights

Why is the United States Market Booming?

The United States is experiencing significant growth in the dural graft market, primarily driven by an increase in Traumatic Brain Injury (TBI) related deaths. Older individuals in the U.S. are more likely to require hospitalization and succumb to TBIs. This trend is attributed to the similarity of TBI symptoms with other common medical conditions among older adults, such as dementia. The Centers for Disease Control and Prevention estimated that over 64,000 Americans died in 2020 due to TBI, equating to approximately 176 fatalities from TBI per day.

Will China Be a Lucrative Market for Dural Graft?

China is emerging as a lucrative market for dural grafts due to the rising incidence of brain and central nervous system tumors. According to the World Health Organization (WHO), China experienced a significant illness burden in 2020, with 79,575 clinically diagnosed brain and CNS tumor patients and 65,204 fatalities. The growing demand for neurological procedures in China is contributing to the market's expansion.

Competitive Landscape Analysis

Key companies in the dural graft market are focusing on increasing production volume, enhancing their line of neurological surgeries, introducing advanced features, and launching innovative products. Many of these companies are forging strategic partnerships with hospital vendors and physicians to accelerate and improve treatments.

Key Companies Covered

• Cook Medical
• Integra Lifesciences Corporation
• B Braun
• Cousin Biotech
• Natus Medical Incorporated
• Tissuemed Ltd
• Vostra Gmbh
• Stryker Corporation
• Medtronic Plc
• Johnson & Johnson
• Baxter International Inc

Key Segments Covered in Dural Graft Industry Research

Product:

• Xenogeneic Dural Graft
• Allogenic Dural Graft
• Synthetic Dural Graft
• Autologous Dural Graft
• Others

Application:

• Traumatic Brain and Spine Injury
• Cerebrovascular Accident
• Cerebrospinal Fluid (CSF) Accumulation
• Brain and Spine Tumor
• Epilepsy
• Others

Material Type:

• Bovine Pericardium
• Cadaveric Dura
• Autologous Pericardium
• Synthetic Bovine Collagen Matrix
• Ligamentum Nuchae
• Others

End User:

• Hospitals
• Ambulatory Surgical Centers
• Trauma Centers
• Clinics

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

This product will be delivered within 1-3 business days.